Top 10 Pharmaceutical Companies in Israel by Market Capitalization

Teva Pharmaceutical Industries Ltd, Taro Pharmaceutical Industries Ltd, UroGen Pharma Ltd, Kamada Pharmaceuticals, and MediWound Ltd are the top 5 pharma companies in Israel in 2023 by market capitalization (as of Mar 31, 2023). Comprehensively, the top 10 Pharma companies in Israel had a total market cap of $11,809 million (as of Mar 31, 2023), with Teva Pharmaceutical Industries Ltd having the highest ($9,936 million), followed by Taro Pharmaceutical Industries Ltd ($914 million), and UroGen Pharma Ltd ($217 million), while Gamida Cell Ltd is the lowest ($60 million). Teva Pharmaceutical Industries Ltd is the world’s leading Pharma company in Israel by market cap (as of Mar 31, 2023). The company reported revenues of $14,925 million for the fiscal year ended December 2022 (FY2022), a decrease of 6% over FY2021. The company provides specialty medicines to treat disorders of the central nervous system (CNS), cancer, respiratory, dermatology, women’s health, and other disease conditions. It employs 34,004 people. Taro Pharmaceutical Industries Ltd is another leading Pharma company in Israel by market cap (as of Mar 31, 2023). The company reported revenues of $561 million for the fiscal year ended March 2022 (FY2022), an increase of 2.3% over FY2021. The company manufactures prescription drugs, nonprescription drugs, and active pharmaceutical ingredients (APIs). It employs 1,455 people.